featured
Perioperative Chemotherapy After RC Can Improve Cure Rates in Urothelial Carcinoma of the Bladder
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Immediate Versus Deferred Chemotherapy After Radical Cystectomy in Patients With pT3-pT4 or N+ M0 Urothelial Carcinoma of the Bladder (EORTC 30994): An Intergroup, Open-Label, Randomised Phase 3 Trial
Lancet Oncol 2014 Dec 10;[EPub Ahead of Print], CN Sternberg, I Skoneczna, JM Kerst, P Albers, SD Fossa, M Agerbaek, H Dumez, M de Santis, C Théodore, MG Leahy, JD Chester, A Verbaeys, G Daugaard, L Wood, JA Witjes, R de Wit, L Geoffrois, L Sengelov, G Thalmann, D Charpentier, F Rolland, L Mignot, S Sundar, P Symonds, J Graham, F Joly, S Marreaud, L Collette, R SylvesterFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.